We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Life Science Research Will Benefit from a New Hands-Free Mini Automated Cell Counter

By LabMedica International staff writers
Posted on 14 Apr 2011
A new instrument for the life science laboratory – a novel hands-free mini automated cell counter – has recently been released to the marketplace.

The Moxi Z mini cell counter is manufactured by ORFLO Technologies (Bothell, WA, USA) who describe it as the first portable instrument to provide cell viability without the use of reagents or dyes.

The Moxi Z combines two powerful methods, the Coulter Principle which is the gold standard for cell counting, and a patented thin-film sensor technology developed by ORFLO to allow particle sizing and counting over a broad size range (two to 34 microns). More...
In just eight seconds per measurement, the instrument provides accurate cell size and count determinations and an indicator of dead versus live cells based on the proprietary Moxi Viability Index. A measurement requires only 75 μl of sample volume in the 3,000 cells/mL to 500,000 cells/mL range, and the Moxi Z's disposable cassettes offer superior ease of use and cost effectiveness.

The instrument is small enough to fit in the palm of one hand, does not require a PC to operate, is easy to clean and does not require that a person hold it while performing a measurement, making it an ideal tool for the hood. Cleaning is simple with ethanol or Isopropyl alcohol.

While the Moxi Z is very robust with few moving parts and has been validated to be extremely stable over time, each unit is supplied with an Electronic Calibration Cassette to allow periodic checks of the accuracy of the instrument.

"The Moxi Z mini cell counter sets a new bar for the cell counting community,” said Manju Sethi, vice president of business development at ORFLO Technologies. "The instrument eliminates virtually all of the drawbacks of current cell counting methods.”

Related Links:
ORFLO Technologies


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.